The findings presented here provide evidence of synergy between NF-κB and STAT5 in transcriptional activation of Bcl-xL in ovarian cancer cells, and also indicate potential molecular pathways to be targeted in order to enhance chemotherapeutic effects. Here, BCL2L1 is linked to ovarian cancer.